Menu
Back to Journals » Clinical Ophthalmology » Volume 17
Original Research
One-Year and 18-Month Outcomes in nAMD Patient Eyes Switched to Brolucizumab Alone versus to Brolucizumab Alternating with Other Anti-VEGF Agents
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 1,951 | Dovepress* | 1,814+ | 49 | 1,863 | |
| PubMed Central* | 137 | 57 | 194 | ||
| Totals | 1,951 | 106 | 2,057 | ||
| *Since 23 November 2023 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 0 | 0 | 0 | 1 | 3 |
View citations on PubMed Central and Google Scholar